PRIORITIZING AND COSTING RMNCH INNOVATIONS FOR SCALABLE IMPACT: A COMBINED MCDA AND COSTING APPROACH FROM ETHIOPIA

Author(s)

Colin Gilmartin, MSc;
Management Sciences for Health, Principal Technical Advisor, Philadelphia, PA, USA
OBJECTIVES: There is growing interest in LMICs in scaling promising health innovations to accelerate national health goals and achieve the 2030 SDGs. Many existing and promising innovations fail to scale up for various reasons, including a lack of evidence on their cost-effectiveness and budgetary impact. Amidst these evidence gaps and limited fiscal space, the objectives of this research are to develop and test an approach for prioritizing and costing reproductive, maternal, newborn, and child health (RMNCH) innovations in Ethiopia and to develop a scale-up plan for their implementation, informed by cost evidence and aligned with available resources from partners and government.
METHODS: In 2025, a comprehensive RMNCH innovation mapping was conducted with the MOH and partners in which more than 100 innovations were identified. A multi-criteria- decision analysis prioritization framework was developed to enable the MOH to assess, prioritize, and select RMNCH innovations using clearly defined criteria. During the MCDA process, participants selected additional criteria and weights—covering impact, feasibility, scalability, cost-effectiveness, sustainability, and alignment with national priorities. Upon shortlisting innovations, detailed costing analyses and resource mapping are underway to determine the financial, logistical, and operational requirements as well as potential resources available for scaling these prioritized innovations.
RESULTS: In the initial MCDA phase, 25 innovations were shortlisted based on selected criteria and weighting. The MCDA process revealed substantial variation in innovation rankings depending on feasibility, system readiness, and equity considerations. Final selection of innovations is currently underway and will be followed by comprehensive costing to inform costed scale-up plans for the MOH.
CONCLUSIONS: Combining MCDA-based prioritization with detailed costing can provide a practical and transparent approach to selection innovations in resource-constrained settings. This approach supports governments in aligning innovation scale-up with affordability, system capacity, and equity objectives while strengthening the link between priority setting and planning.

Conference/Value in Health Info

2026-05, ISPOR 2026, Philadelphia, PA, USA

Value in Health, Volume 29, Issue S6

Code

HTA49

Topic

Health Technology Assessment

Topic Subcategory

Decision & Deliberative Processes

Disease

No Additional Disease & Conditions/Specialized Treatment Areas, SDC: Reproductive & Sexual Health

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×